431 related articles for article (PubMed ID: 33322413)
21. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.
Razavi BM; Ghasemzadeh Rahbardar M; Hosseinzadeh H
Phytother Res; 2021 Dec; 35(12):6489-6513. PubMed ID: 34312922
[TBL] [Abstract][Full Text] [Related]
22. [Turmeric - not only spice].
Zdrojewicz Z; Szyca M; Popowicz E; Michalik T; Śmieszniak B
Pol Merkur Lekarski; 2017 Jun; 42(252):227-230. PubMed ID: 28662006
[TBL] [Abstract][Full Text] [Related]
23. Curcumin attenuates lipopolysaccharide-induced renal inflammation.
Zhong F; Chen H; Han L; Jin Y; Wang W
Biol Pharm Bull; 2011; 34(2):226-32. PubMed ID: 21415532
[TBL] [Abstract][Full Text] [Related]
24. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
25. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Ramachandran C; Nair SM; Escalon E; Melnick SJ
J Complement Integr Med; 2012 Aug; 9():Article 20. PubMed ID: 22944718
[TBL] [Abstract][Full Text] [Related]
27. Curcumin: a Polyphenol with Molecular Targets for Cancer Control.
Qadir MI; Naqvi ST; Muhammad SA
Asian Pac J Cancer Prev; 2016; 17(6):2735-9. PubMed ID: 27356682
[TBL] [Abstract][Full Text] [Related]
28. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
Soleimani V; Sahebkar A; Hosseinzadeh H
Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
[TBL] [Abstract][Full Text] [Related]
29. Curcumin, a component of golden spice: from bedside to bench and back.
Prasad S; Gupta SC; Tyagi AK; Aggarwal BB
Biotechnol Adv; 2014 Nov; 32(6):1053-64. PubMed ID: 24793420
[TBL] [Abstract][Full Text] [Related]
30. CURCUMA LONGA AS MEDICINAL HERB IN THE TREATMENT OF DIABET- IC COMPLICATIONS.
Karlowicz-Bodalska K; Han S; Freier J; Smolenski M; Bodalska A
Acta Pol Pharm; 2017 Mar; 74(2):605-610. PubMed ID: 29624265
[TBL] [Abstract][Full Text] [Related]
31. Curcumin as a therapeutic agent in leukemia.
Kouhpeikar H; Butler AE; Bamian F; Barreto GE; Majeed M; Sahebkar A
J Cell Physiol; 2019 Aug; 234(8):12404-12414. PubMed ID: 30609023
[TBL] [Abstract][Full Text] [Related]
32. Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini-Review.
Slika L; Patra D
Mini Rev Med Chem; 2020; 20(12):1072-1082. PubMed ID: 32286941
[TBL] [Abstract][Full Text] [Related]
33. Curcumin and lung cancer--a review.
Mehta HJ; Patel V; Sadikot RT
Target Oncol; 2014 Dec; 9(4):295-310. PubMed ID: 24840628
[TBL] [Abstract][Full Text] [Related]
34. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
Tyagi AK; Prasad S; Yuan W; Li S; Aggarwal BB
Invest New Drugs; 2015 Dec; 33(6):1175-86. PubMed ID: 26521943
[TBL] [Abstract][Full Text] [Related]
36. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications.
Sharifi-Rad J; Rayess YE; Rizk AA; Sadaka C; Zgheib R; Zam W; Sestito S; Rapposelli S; Neffe-Skocińska K; Zielińska D; Salehi B; Setzer WN; Dosoky NS; Taheri Y; El Beyrouthy M; Martorell M; Ostrander EA; Suleria HAR; Cho WC; Maroyi A; Martins N
Front Pharmacol; 2020; 11():01021. PubMed ID: 33041781
[TBL] [Abstract][Full Text] [Related]
37. Multiple health benefits of curcumin and its therapeutic potential.
Shah M; Murad W; Mubin S; Ullah O; Rehman NU; Rahman MH
Environ Sci Pollut Res Int; 2022 Jun; 29(29):43732-43744. PubMed ID: 35441996
[TBL] [Abstract][Full Text] [Related]
38. Coupling to a glioblastoma-directed antibody potentiates antitumor activity of curcumin.
Langone P; Debata PR; Inigo Jdel R; Dolai S; Mukherjee S; Halat P; Mastroianni K; Curcio GM; Castellanos MR; Raja K; Banerjee P
Int J Cancer; 2014 Aug; 135(3):710-9. PubMed ID: 24142484
[TBL] [Abstract][Full Text] [Related]
39. Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications.
Hu RW; Carey EJ; Lindor KD; Tabibian JH
Ann Hepatol; 2017 November-December,; 16(6):835-841. PubMed ID: 29055920
[TBL] [Abstract][Full Text] [Related]
40. Curcumin: a novel treatment for skin-related disorders.
Nguyen TA; Friedman AJ
J Drugs Dermatol; 2013 Oct; 12(10):1131-7. PubMed ID: 24085048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]